top of page
Osteal Therapeutics has completed two prospective, randomized controlled trials comparing VT-X7 to standard of care, two-stage exchange arthroplasty.
For information on protocol design and participating sites for APEX, click here and for APEX-2 click here.
For information on the expanded access program, click here.
For information on VT-X7, click here.
bottom of page
